Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03157986
Other study ID # WBVT Balance Study
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2017
Est. completion date August 16, 2019

Study information

Verified date December 2019
Source Schön Klinik Berchtesgadener Land
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim of this study is to compare the effects of whole-body Vibration Training versus conventional Balance Training on Balance performance, gait quality and exercise capacity in patients with severe chronic obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized into one of two intervention groups. On top of a standardized endurance and strength Training program (5 days per week) patients in both groups will perform an additional Balance Training (on 3 days per week). Patients in both Groups will perform the same 4 different Balance exercises (2x1 Minute each): dynamic squats with closed eyes, heel raise, semi-Tandem stance and single leg stance but on a different surface. The Vibration Training Group will perform the exercises on a side-alternating Vibration platform (Galileo) at frequencies between 15 to 26 Hertz and the control Group will perform exercises on instable objects like Balance pads. The degree of difficulty in both Groups will be individually adjusted and will be progressively increased, if possible.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date August 16, 2019
Est. primary completion date August 16, 2019
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria:

- COPD stage III or IV according to the global initiative for chronic obstructive lung disease

- impaired exercise capacity (6 Minute walk distance of less than 70% of the reference value from Troosters et al.)

Exclusion Criteria:

- current acute exacerbation of COPD

- carbon dioxide pressure of more than 45 mmHg at rest

- any contraindication for vibration Training (e.g. acute deep vein thrombosis)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Balance Training on a vibration platform
n=24 patients with severe chronic obstructive pulmonary disease. Exercises will be performed on a side-alternating Vibration platform (Galileo) at frequencies between 15 to 26 Hertz.
Conventional Balance training
n=24 patients with COPD, Exercises will be performed on a Balance pad

Locations

Country Name City State
Germany Schön Klinik Berchtesgadener Land Schoenau Am Koenigssee Bavaria

Sponsors (1)

Lead Sponsor Collaborator
Schön Klinik Berchtesgadener Land

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Balance Performance during semi Tandem stance patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force. measurement on Day 1 and 21
Secondary Change in muscle power during counter movement jump patients jump on a force platform as high as possible. The Outcome is Watt per Kilogram Body weight measurement on Day 1 and 21
Secondary Change in performance of the 5-Repetition-Raise-Test Patients try to perform 5 repetitions of standing up and sitting down from a chair with crossed arms on a force platform as quick as possible measurement on Day 1 and 21
Secondary Change in performance of the 1-Minute-Chair-Rise-Test Patients try to perform as many repetitions as possible of standing up and sitting down from a chair with crossed arms on a force platform during 1 minute measurement on Day 1 and 21
Secondary Change in Peak muscle strength of the knee Extension muscles isometric peak torque of the knee extensor muscles are measured in 90° knee angle measurement on Day 1 and 21
Secondary Change in Peak muscle strength of the knee Flexion muscles isometric peak torque of the knee flexor muscles are measured in 90° knee angle measurement on Day 1 and 21
Secondary Change in 6-minute Walk Distance patients are advised to walk as far as possible on a 30m track measurement on Day 1 and 21
Secondary Change in 4m Gait Speed Test patients have to walk 4 meters at their usual Speed. Outcome is the average Speed during the 4m walk. measurement on Day 1 and 21
Secondary Change in step symmetry during 20m walking Patients walk 20m while wearing the Mc Roberts move test device (triaxial accelerometer) which performs a gait analysis measurement on Day 1 and 21
Secondary Change in Hospital anxiety and Depression scale the Hospital anxiety and Depression scale is a questionnaire that evaluates signs of anxiety or depression measurement on Day 1 and 21
Secondary Change in balance performance during Romberg stance patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force. measurement on Day 1 and 21
Secondary Change in Balance Performance during 1-leg stance patients stand still for 10 seconds with closed eyes on a force platform that measures absolute path length of the center of force. measurement on Day 1 and 21
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy